-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Persistent symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are prevalent for weeks to months after infection
Infect
A study published in the Journal of Internal Medicine, an authoritative journal in the field of internal medicine, aims to describe the prevalence of symptoms at 12 months in outpatient individuals who tested positive for SARS-CoV-2 and those who tested negative.
Quality of Life
From April 23 to July 27, 2021, we included symptomatic outpatient individuals who were tested for SARS-CoV-2 at the University Hospital of Geneva and followed up within 12 months of the test date
At the end of 12 months of follow-up, among 1447 participants (mean age 45.
Thus, SARS-CoV-2 infection can cause symptoms that persist for months, including in young healthy individuals, in addition to the effects of the pandemic, and may be more severe than other common respiratory infections
SARS-CoV-2 infection causes symptoms that persist for months, including in young healthy individuals, in addition to the effects of the pandemic, and may be more severe than other common respiratory infections
Original source:
Mayssam Nehme, et al.
1-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals
leave a comment here